Novo Integrated Sciences, Inc. (NVOS)
OTCMKTS
· Delayed Price · Currency is USD
0.0035
+0.0004 (12.90%)
At close: Mar 6, 2026
Novo Integrated Sciences Revenue
In the fiscal year ending August 31, 2024, Novo Integrated Sciences had annual revenue of $13.29M with 5.75% growth. Novo Integrated Sciences had revenue of $3.08M in the quarter ending August 31, 2024, a decrease of -6.74%.
Revenue
13.29M
Revenue Growth
+5.75%
P/S Ratio
0.01
Revenue / Employee
69.97K
Employees
264
Market Cap
69.06K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 13.29M | 722.34K | 5.75% |
| Aug 31, 2023 | 12.57M | 834.08K | 7.11% |
| Aug 31, 2022 | 11.74M | 2.43M | 26.14% |
| Aug 31, 2021 | 9.31M | 1.44M | 18.38% |
| Aug 31, 2020 | 7.86M | -1.56M | -16.57% |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clearday | 7.06M |
| First Choice Healthcare Solutions | 25.49K |
| MedSmart Group | 726.81K |
| Healthcare Solutions Management Group | 9.25M |
| ModivCare | 2.69B |
| IMAC Holdings | 22.72K |
| Primemd | 69.98K |
| Banyan | 3.48M |